IP Library Patent Application 11346884
Patent Application
App. No. 11/346,884

Steady state perfusion methods

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
11/346,884
Abstract

Methods for assessing ischemic coronary artery disease are provided. The methods include administering a contrast agent that binds to a serum protein component to an animal and obtaining an MR image of the animal's myocardium during a period when the animal is experiencing hyperemia.

Claims (21)

1 . An MR method of assessing the presence or absence of ischemic coronary artery disease comprising:

a) administering intravenously to an animal a MR contrast agent which noncovalently binds to a serum protein component; and

b) obtaining at least one MRI scan of said animal's myocardium during a period when said animal is experiencing a hyperemic response, provided that said at least one hyperemic MRI scan occurs at a time period when said contrast agent is in steady-state equilibrium in the blood of said animal.

2 . The method of claim 1 , wherein said at least one hyperemic MRI scan is obtained at least 3 minutes after said intravenous administration of said contrast agent.

3 . The method of claim 1 , further comprising obtaining at least one MRI scan of said animal's myocardium during a period of rest of said animal, provided that said at least one rest MRI scan occurs at a time period when said contrast agent is in steady-state equilibrium in the blood of said animal.

4 . The method of claim 1 , wherein said serum protein component is HSA.

5 . The method of claim 1 , wherein said contrast agent is MS-325.

6 . The method of claim 1 , wherein about 0.01 to about 0.2 mmol/kg of said contrast agent is injected.

7 . The method of claim 1 , wherein said hyperemic response is obtained by administering a pharmacologic stress agent to said animal.

8 . The method of claim 7 , wherein said pharmacologic stress agent is an A 2A agonist.

9 . The method of claim 7 , wherein said pharmacologic stress agent is selected from adenosine, dipyridamole, and dobutamine.

10 . The method of claim 1 wherein the hyperemic response is produced by physical stress.

11 . The method of claim 10 , wherein said physical stress is the result of exercise utilizing a bicycle or a treadmill device.

12 . The method of claim 3 , further comprising comparing the at least one rest MRI scan to the at least one hyperemic MRI scan.

13 . The method of claim 1 , further comprising obtaining at least one MRI scan of a coronary artery of said animal at any time after step a).

14 . The method of claim 1 , further comprising determining the degree or severity of ischemic coronary artery disease.

15 . The method of claim 7 , wherein an antidote to the pharmacologic stress agent is administered to end the hyperemic response.

16 . The method of claim 15 , wherein at least one MRI rest scan of said animal's myocardium is obtained after said administration of said antidote, wherein a hyperemic response in said animal is re-attained upon administration of a second dose of a pharmacologic stress agent, and wherein at least one MRI scan of said animal's myocardium is obtained during said second period of hyperemic response.

17 . An MR method of assessing the presence or absence of ischemic coronary artery disease comprising:

a) administering intravenously to an animal a MR contrast agent which is not covalently bound to a serum protein component; and

b) obtaining at least one MRI scan of said animal's myocardium during a period when said animal is experiencing a hyperemic response, provided that said at least one hyperemic MRI scan occurs at a time period when said contrast agent is in steady-state equilibrium in the blood of said animal.

Assignments (7)
RELEASE OF SECURITY INTEREST IN CERTAIN PATENTS Recorded Mar 30, 2017
From: WELLS FARGO BANK, NATIONAL ASSOCIATION
To: LANTHEUS HOLDINGS, INC.; LANTHEUS MEDICAL IMAGING, INC.; LANTHEUS MI REAL ESTATE, LLC
Reel/Frame 042115/0715 →
ASSIGNMENT OF SECURITY INTEREST IN PATENTS Recorded Jul 3, 2013
From: BMO HARRIS BANK N.A.
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS ASSIGNEE
Reel/Frame 030740/0335 →
SECURITY AGREEMENT Recorded May 13, 2010
From: LANTHEUS MEDICAL IMAGING, INC.
To: HARRIS N.A., AS COLLATERAL AGENT
Reel/Frame 024390/0733 →
RELEASE OF PATENT SECURITY AGREEMENT Recorded May 13, 2010
From: ABLECO FINANCE LLC
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 024380/0363 →
GRANT OF SECURITY INTEREST Recorded Jun 2, 2009
From: LANTHEUS MEDICAL IMAGING, INC.
To: ABLECO FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 022764/0376 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 7, 2009
From: EPIX PHARMACEUTICALS, INC.
To: LANTHEUS MEDICAL IMAGING, INC.
Reel/Frame 022510/0499 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 25, 2006
From: WEISSKOFF, ROBERT M.
To: EPIX PHARMACEUTICALS, INC.
Reel/Frame 017524/0256 →